Luisa M. Stamm
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, HIV/AIDS drug development and treatment, Systemic Lupus Erythematosus Research
Most-Cited Works
- → Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection(2017)559 cited
- → Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1(2015)465 cited
- → Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes(2018)307 cited
- → Mycobacterium marinum Escapes from Phagosomes and Is Propelled by Actin-based Motility(2003)289 cited
- → Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials(2017)236 cited
- → Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus(2014)195 cited
- → Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial(2018)120 cited
- → Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial(2018)111 cited
- → Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis(2018)93 cited
- → Deltamethrin-impregnated dog collars have a potent anti-feeding and insecticidal effect on Lutzomyia longipalpis and Lutzomyia migonei(2001)93 cited